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Some tripeptides obtained by enzymic digestion of caseins possess immunomodulating properties. In order 
to correlate activity and structure, X-ray analysis has been applied to two of them Leu-Leu-Tyr and Gly- 
Leu-Phe. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The major part of the studies so far devoted to 
chemically defined immunomodulating substances 
has been performed with compounds of bacterial 
origin or with their synthetic analogues [1]. How- 
ever, we previously observed that enzymic frag- 
ments obtained from human casein, the main 
protein fraction of maternal milk which is usually 
man's first food, exhibit immunostimulating 
properties [2]. The purification, the sequence, the 
synthesis and some biological properties of an im- 
munostimulating hexapeptide (Val-Glu-Pro-Ile- 
Pro-Tyr) from human fl-casein have been de- 
scribed [3]. The presence of some further biologi- 
cally active short peptides has been detected in 
human as well as in cow milk caseins. This paper 
deals with the characterization of two active 
tripeptides (Gly-Leu-Phe and Leu-Leu-Tyr) and 
their molecular conformation i the solid state by 
single crystal X-ray diffraction, as a first attempt 
to correlate biological activity and structure. 
Correspondence address: P. Joll~s, Laboratory of Pro- 
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2.1. Purif ication procedures 
Two peptides Gly-Leu-Phe and Leu-Leu-Tyr 
were obtained from delipidated casein digested by 
non-pretreated trypsin (Worthington): the digest 
was filtered on Sephadex G-50 (Pharmacia) [2]. 
Biologically active fractions were submitted to suc- 
cessive chromatographies. Gly-Leu-Phe, from 
human casein, was obtained after DEAE-Sepha- 
dex A-25 chromatography (fraction III), filtration 
on Sephadex G-15, Dowex 50 x 4 chromatography 
(Bio-Rad) and HPLC [3]. The last HPLC (Waters 
chromatograph, model ALC/GPC 204) was 
achieved on a/zBondapak C18 column (300×9 
mm; Waters associates) eluted at a flow rate of 1 
ml/min with a buffer containing 5.5°70 acetonitrile 
(Baker chemicals) in 0.1070 trifluoroacetic acid 
(TFA; Uvasol, Merck). Leu-Leu-Tyr, from bovine 
casein, was obtained after CM-Trisacryl M (IBF) 
chromatography with a 0.01 M Tris-HCl, pH 4.5, 
buffer and HPLC (Gilson Chromatograph) with 
the same column as above. The ultimate HPLC 
was achieved with a buffer containing 12.5070 
acetonitrile in 0.1070 TFA. The corresponding syn- 
thetic peptides were obtained from Bachem. 
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2.2. Biological assays 
2.2.1. In vitro test 
Stimulation of phagocytosis of sheep red blood 
cells (SRBC) by murine peritoneal macrophages [3] 
was expressed as the increase in the number of 
macrophages which had at least ingested two 
SRBC for a total of 100 cells examined. Stimula- 
tion of secretion of hemolytic antibodies against 
SRBC by murine spleen cells [3] was expressed as 
the increase in the percentage of hemolysis mea- 
sured by absorbance at 542 nm. 
2.2.2. In vivo test 
Resistance of mice against infection with Kleb- 
siella pneumoniae [3] was tested after administra- 
tion of various doses of peptides 24 h before 
infectious challenge. Animals were observed 10 
days following infection, mortality being recorded 
daily. 
2.3. Crystallization 
Leu-Leu-Tyr crystals were obtained from a 
dimethylformamide/water (2:1, v/v) mixture and 
Gly-Leu-Phe crystals from a methanol/water (1 :3, 
v/v) one, by slow evaporation at room tempera- 
ture. Both were very thin needle-shaped crystals 
elongated along the c axis. Leu-Leu-Tyr crystal- 
lized as a chloride and Gly-Leu-Phe as a hydrate. 
2.4. X-ray analysis and structure determination 
The crystals were analyzed by X-ray techniques. 
Parameters and space groups were determined 
from Weissenberg camera photographs. The data 
sets were collected on a Philips PW 1100 single 
crystal automatic diffractometer with CuK~ radia- 
tion, A = 0.15418 nm. The crystals were mounted 
along the c axis. The structure determinations were 
solved by direct methods [5] and refined by the 
full-matrix least-squares methods using the Affine 
program [6] with an isotropic temperature factor 
for all atoms except he hydrogens. 
Table 1 
Immunostimulant activities of two casein tripeptides 
Peptides Stimulation of phagocytosis a Enhancement of resistance against Klebsiella pneumoniae b 
Concentration % stimulation Way of Doses Mean survival Survival on Index of P~ 
~uM) injection (mg/kg) time (days) day + 10 stimu- 
lation 
ts (tc) 
Assay I Assay 2 
Gly-Leu-Phe 30 146 (28.6) 151 (28) i.v. 5 4.7 (2.67) 6/15 (4/30) 176 13.55 
1 4.6 4/15 172 1.35 
3 160 157 
s.c. 5 3.4 (2.67) 3/15 (4/30) 127 41.27 
0.3 127 121 1 5.5 7/15 2~5 4.19 
Leu-Leu-Tyr 30 148 (28.6) 141 (28) 
3 145 148 
0.3 122 128 
Stimulation of antibody secretion against SRBC c 
Concentration % hemolysis °7o stimulation P~ 
~M) 
10 52.6 (45) 116 0.043 
1 41.0 90.6 0.161 
a Figures indicate % increase in phagocytosis over controls x 100. Between parentheses are the values of % phagocytosis 
in control cultures. Underlined figures are significantly different from controls (t-test of Student-Fisher) 
b An index, ts/tc × 100, was calculated for each experimental group (ts = mean survival time of treated mice, tc = 
mean survival time of control mice). Statistical analysis was performed by the distribution-free K-sample test of 
Jonkheere [4] to determine significant results (P¢5, underlined figures) 
¢ Figures indicate the °7o increase in hemolytic antibody secretion over controls x 100. Between parentheses are the 
values of % hemolysis in controls. Underlined figures are significantly different from controls (t-test of Student- 
Fisher) 
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Fig. 1. Conformation of Leu-Leu-Tyr (a) and Gly-Leu-Phe (b) tripeptides. Molecular conformations are seen along the 
c axis. 
3. RESULTS AND DISCUSSION 
3.1. Immunostimulating properties 
An enzymic digest of human casein was submit- 
ted to a series of chromatographic purification 
steps and of immunomodulating tests, and an ac- 
tive tripeptide was characterized (table 1). The 
natural as well as the synthetic peptide Gly-Leu- 
Phe showed a significant activity on the phago- 
cytosis of SRBC by mouse peritoneal macro- 
phages; furthermore it protected the mice against 
an infection with KI. pneumoniae at 1 mg/kg when 
administered subcutaneously and to a lesser but 
still significant degree intravenously. The ana- 
logous peptide Gly-Phe-Leu which also occurs in 
human casein displayed also weak but significant 
activities when the same biological tests were used. 
The peptide Leu-Leu-Tyr from cow casein in- 
creased again the phagocytosis of SRBC by mouse 
macrophages but failed to protect he mice against 
infection with Ki. pneumoniae; however it slightly 
but significantly stimulated the antibody secretion 
against SRBC by murine spleen cells. 
3.2. X-ray analysis and molecular conformation 
The crystal parameters determined by X-ray 
techniques were for peptide Leu-Leu-Tyr, which 
crystallized in the orthorhombic system, space 
group P2~2121: a = 26.074/k, b = 17.591 A, c = 
5.224 A. For peptide Gly-Leu-Phe, which crystal- 
lized in the monoclinic system, space group B2, the 
parameters were: a -- 18.229 ,~,, b = 18.781 A, c 
-- 5.917 A, 7 = 110°65. The two structures were 
refined up to a R = 8°7o and 5%, respectively [6]. 
Fig. 1 shows the structure of each peptide mole- 
cule. Their molecular conformations are defined 
by the torsion angles [7] from which some remarks 
can be drawn: (a) all the peptide bonds are in trans- 
conformation and all Ccr-CONH-Cxr groups 
deviate very slightly from planarity (w: 180°); (b) 
in peptide Leu-Leu-Tyr, the two ~ values are of the 
same magnitude ( -100  ° and -88  °) indicating 
that it is already taking a regular helix conforma- 
tion, whereas in peptide Gly-Leu-Phe the molecule 
has a more stretched conformation as the 
phenylalanine r sidue has a ~ value of - 174°8; (c) 
the side chains are very agitated as shown by ther- 
mal ellipsoids (fig. 1). 
The crystal packing of the two tripeptides is 
shown in fig.2. As expected no intramolecular 
hydrogen bonds were observed. The molecules are 
held together through an intermolecular hydrogen 
bond network. In both peptides hydrogen bonds 
occur between a carbonyl group and the amino 
group of a neighbouring molecule. The stacking of 
the molecules along the c axis is a result of the Van 
der Waals forces. Peptide Gly-Leu-Phe has a zwit- 
terion ion structure as suggested by its carboxyl 
group dimensions (C-O: 1.22 ,~,), while the water 
molecules contribute to the stabilization of the 
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Fig.2. Crystal structures of Leu-Leu-Tyr (a) and Gly-Leu-Phe (b). The crystal structures are viewed along the c axis. 
whole. In peptide Leu-Leu-Tyr, the amino end is 
charged (NH~-) and stabilized by C1-. 
The striking feature of the crystal structure of 
peptide Gly-Leu-Phe is the hydrophobic hannel 
made up of leucine and phenylalanine residues 
packed together along the a axis, while all hydro- 
philic groups are clustered outside the channel. 
The segregation of the hydrophobic side chains 
contributes to stabilize the peptide crystal struc- 
ture. Whether the extended conformation of this 
tripeptide is a molecular property or results from 
crystal packing remains to be checked. 
The aim of this study is to initiate a correlation 
between the structures and biological activities of 
immunostimulating peptides and later to deduce 
the topology of their biological targets. The pre- 
sent note reports for the first time the three- 
dimensional structures of two immunostimulating 
peptides: other related structures are currently 
58 
under investigation as obviously further data must 
be accumulated. 
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